Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""generic"" wg kryterium: Temat


Tytuł:
Bioequivalence trials for the approval of generic drugs in Saudi Arabia: a descriptive analysis of design aspects.
Autorzy:
Althunian TA; Research Informatics Department, Saudi Food and Drug Authority, Riyadh, Saudi Arabia. .; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. .
Alzenaidy BR; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alroba RA; Research Informatics Department, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Almadani OA; Research Informatics Department, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alqahtani FA; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Binajlan AA; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Almousa AI; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alamr DK; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Al-Mofada MS; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alsaqer NY; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alarfaj HA; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Bahlewa AA; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alharbi MA; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alhomaidan AM; Executive Department of Research and Studies, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alsuwyeh AA; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alsaleh AA; Department of Pharmacokinetics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2024 Apr 05; Vol. 24 (1), pp. 82. Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Drugs, Generic*/therapeutic use
Humans ; Therapeutic Equivalency ; Saudi Arabia ; Retrospective Studies ; Sample Size
Czasopismo naukowe
Tytuł:
Characteristics and outcomes of the drug patent linkage system in China.
Autorzy:
Yao XF; School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China. sarina_.
Pokaż więcej
Źródło:
Globalization and health [Global Health] 2024 Apr 15; Vol. 20 (1), pp. 31. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:
Journal Article
MeSH Terms:
Internationality*
Drugs, Generic*
Humans ; Republic of Korea ; China
Czasopismo naukowe
Tytuł:
Crushing tablets or sprinkling capsules: Implications for clinical strategy and study performance based on BE studies of rivaroxaban and deferasirox.
Autorzy:
Sus J; Zentiva, k.s., Prague, Czech Republic.
Bosak J; Zentiva, k.s., Prague, Czech Republic.
Hauser T; Zentiva, k.s., Prague, Czech Republic.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13752.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Rivaroxaban*
Drugs, Generic*
Humans ; Therapeutic Equivalency ; Deferasirox ; Administration, Oral ; Tablets
Czasopismo naukowe
Tytuł:
A comparative study on vildagliptin brand and its generic equivalents using dissolution test as quality control measure tool.
Autorzy:
Altoum GH; Research and Laboratories Sector, National Drug and Cosmetic Control Laboratories (NDCCL), Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Al-Enazi FK; Research and Laboratories Sector, National Drug and Cosmetic Control Laboratories (NDCCL), Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Abudahash MM; Research and Laboratories Sector, National Drug and Cosmetic Control Laboratories (NDCCL), Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Al-Fadhli RA; Research and Laboratories Sector, National Drug and Cosmetic Control Laboratories (NDCCL), Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Alenzi N; Research and Laboratories Sector, National Drug and Cosmetic Control Laboratories (NDCCL), Saudi Food and Drug Authority, Riyadh, Saudi Arabia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 01; Vol. 14 (1), pp. 2636. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Drugs, Generic*/therapeutic use
Hypoglycemic Agents*
Vildagliptin ; Quality Control ; Tablets
Czasopismo naukowe
Tytuł:
TCP BBR-n: Increased throughput for wireless-AC networks.
Autorzy:
Ahsan M; Department of Electrical Engineering, National University of Computer & Emerging Sciences, Lahore, Punjab, Pakistan.
Muhammad SS; Department of Electrical Engineering, National University of Computer & Emerging Sciences, Lahore, Punjab, Pakistan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 11; Vol. 18 (12), pp. e0295576. Date of Electronic Publication: 2023 Dec 11 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Algorithms*
Drugs, Generic*
Kidney ; Physical Examination ; Reading Frames
Czasopismo naukowe
Tytuł:
Global harmonization of immediate-release solid oral drug product bioequivalence recommendations and the impact on generic drug development.
Autorzy:
Kotsybar J; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Hakeem S; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Zhang L; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Jiang W; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Dec; Vol. 16 (12), pp. 2756-2764. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Drugs, Generic*
Drug Development*
Humans ; Therapeutic Equivalency ; Pharmaceutical Preparations ; Administration, Oral
Czasopismo naukowe
Tytuł:
Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study.
Autorzy:
Lim YC; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-Do, South Korea.
Lee EK; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-Do, South Korea. .
Park MH; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-Do, South Korea. .
Pokaż więcej
Źródło:
Lipids in health and disease [Lipids Health Dis] 2023 Sep 13; Vol. 22 (1), pp. 151. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Drug Substitution*
Drugs, Generic*/therapeutic use
Humans ; Atorvastatin/therapeutic use ; Cholesterol, LDL ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Upper limb modeling and motion extraction based on multi-space-fusion.
Autorzy:
Wang H; State Key Laboratory of Robotics and System, Harbin Institute of Technology, Harbin, 150001, China.
Guo J; State Key Laboratory of Robotics and System, Harbin Institute of Technology, Harbin, 150001, China.
Pei S; State Key Laboratory of Robotics and System, Harbin Institute of Technology, Harbin, 150001, China.
Wang J; State Key Laboratory of Robotics and System, Harbin Institute of Technology, Harbin, 150001, China.
Yao Y; State Key Laboratory of Robotics and System, Harbin Institute of Technology, Harbin, 150001, China. .; Tianzhi Institute of Innovation and Technology, Weihai, 264209, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 26; Vol. 13 (1), pp. 16101. Date of Electronic Publication: 2023 Sep 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drugs, Generic*
Technology*
Humans ; Motion ; Upper Extremity
Czasopismo naukowe
Tytuł:
Generalized measurement error: Intrinsic and incidental measurement error.
Autorzy:
Kroc E; Measurement, Evaluation, and Research Methodology, University of British Columbia, Vancouver, British Columbia, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jun 29; Vol. 18 (6), pp. e0286680. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Drugs, Generic*
Probability Theory*
Humans ; Research Personnel
Czasopismo naukowe
Tytuł:
Robust morphogenesis by chaotic dynamics.
Autorzy:
Reinitz J; Departments of Statistics, Ecology and Evolution, Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL, 60637, USA.
Vakulenko S; Institute for Problems in Mechanical Engineering, Russian Academy of Sciences, Saint Petersburg, 199178, Russia.; Saint Petersburg Electrotechnical University, Saint Petersburg, 197022, Russia.
Sudakow I; School of Mathematics and Statistics, The Open University, Milton Keynes, MK7 6AA, UK. .
Grigoriev D; CNRS, Mathématiques, Université de Lille, Villeneuve d'Ascq, 59655, France.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 09; Vol. 13 (1), pp. 7482. Date of Electronic Publication: 2023 May 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Drugs, Generic*
RNA*
Morphogenesis
Czasopismo naukowe
Tytuł:
Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers.
Autorzy:
Jayachandran P; Clinical Pharmacology & Bioanalytics, Pfizer Inc., Cambridge, MA, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 May; Vol. 12 (5), pp. 549-551. Date of Electronic Publication: 2023 Apr 27.
Typ publikacji:
Editorial
MeSH Terms:
Drugs, Generic*
Learning*
Humans ; Therapeutic Equivalency
Opinia redakcyjna
Tytuł:
Mechanistic modeling of generic orally inhaled drug products: A workshop summary report.
Autorzy:
Walenga RL; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Butler C; Inhaled Drug Product Research and Development Division, Teva Pharmaceuticals Ireland, Waterford, Ireland.
Craven BA; Division of Applied Mechanics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA.
Longest PW; Virginia Commonwealth University, Richmond, Virginia, USA.
Mohamed R; Novartis Healthcare Private Ltd, Sandoz Development Centre (SDC), India.
Newman B; Division of Therapeutic Performance I, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Olsson B; Emmace Consulting AB, Lund, Sweden.
Hochhaus G; Department of Pharmaceutics, University of Florida, Gainesville, Florida, USA.
Li BV; Office of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Luke MC; Division of Therapeutic Performance I, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zhao L; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Przekwas A; CFD Research Corporation, Huntsville, Alabama, USA.
Lionberger R; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 May; Vol. 12 (5), pp. 560-574. Date of Electronic Publication: 2022 Dec 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Research Report*
Drugs, Generic*
Humans ; Therapeutic Equivalency ; Administration, Inhalation ; Computer Simulation
Czasopismo naukowe
Tytuł:
Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview.
Autorzy:
Babiskin A; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Wu F; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Mousa Y; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Tan ML; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Tsakalozou E; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Walenga RL; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Yoon M; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Raney SG; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Polli JE; Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland, USA.
Schwendeman A; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Krishnan V; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Fang L; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zhao L; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 May; Vol. 12 (5), pp. 619-623. Date of Electronic Publication: 2023 Feb 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drugs, Generic*/pharmacokinetics
United States ; Humans ; Therapeutic Equivalency ; Computer Simulation ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł:
Mechanistic modeling of ophthalmic, nasal, injectable, and implant generic drug products: A workshop summary report.
Autorzy:
Tan ML; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Chandran S; Advanced Drug Delivery Research and IVIVC/Biopharmaceutics, Pharmaceutical R & D, Lupin Ltd., Pune, India.
Jereb R; Clinical Development, Sandoz Development Centre, Ljubljana, Slovenia.
Alam K; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Bies R; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at BuffaloBuffalo, New York, USA.
Kozak D; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Walenga R; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Le Merdy M; Simulations Plus, Inc., Lancaster, California, USA.
Babiskin A; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 May; Vol. 12 (5), pp. 631-638. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drugs, Generic*/pharmacokinetics
Research Report*
Humans ; Pharmaceutical Preparations ; Therapeutic Equivalency
Czasopismo naukowe
Tytuł:
Establishing the suitability of model-integrated evidence to demonstrate bioequivalence for long-acting injectable and implantable drug products: Summary of workshop.
Autorzy:
Gong Y; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zhang P; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Yoon M; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zhu H; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Kohojkar A; Regulatory Affairs, Teva Pharmaceuticals, Fairfield, New Jersey, USA.
Hooker AC; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Ducharme MP; Learn and Confirm Inc., St. Laurent, Quebec, Canada.
Gobburu J; Center for Translational Medicine, School of Pharmacy, University of Maryland, College Park, Maryland, USA.
Cellière G; Simulations Plus, Lixoft Division, Paris, France.
Gajjar P; Seda Pharmaceutical Development Services, Cheadle, UK.
Li BV; Office of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Velagapudi R; Sandoz Inc., East Hanover, New Jersey, USA.
Tsang YC; Apotex Inc., Toronto, Ontario, Canada.
Schwendeman A; Department of Pharmaceutical Sciences, Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan, USA.
Polli J; Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, College Park, Maryland, USA.
Fang L; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Lionberger R; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zhao L; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 May; Vol. 12 (5), pp. 624-630. Date of Electronic Publication: 2023 Feb 09.
Typ publikacji:
Journal Article; Review; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Drugs, Generic*
United States ; Humans ; Therapeutic Equivalency ; United States Food and Drug Administration ; Computer Simulation
Czasopismo naukowe
Tytuł:
Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective.
Autorzy:
Manolis E; European Medicines Agency, Amsterdam, The Netherlands.
García-Arieta A; Spanish Agency of Medicines and Medical Devices, Madrid, Spain.
Lindahl A; Swedish Medical Products Agency, Uppsala, Sweden.
Kotzagiorgis E; European Medicines Agency, Amsterdam, The Netherlands.
Limberg J; Federal Institute of Drugs and Medical Devises, Bonn, Germany.
Holte Ø; Norwegian Medicines Agency, Oslo, Norway.
Paixao P; INFARMED - National Authority of Medicines and Health Products, Lisbon, Portugal.
Versantvoort C; Medicines Evaluation Board, Utrecht, The Netherlands.
Tshinanu FM; Federal Agency for Medicines and Health Products, Brussels, Belgium.
Blake K; European Medicines Agency, Amsterdam, The Netherlands.
Van Den Heuvel M; Medicines Evaluation Board, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 May; Vol. 12 (5), pp. 556-559. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Drugs, Generic*
Drug Approval*
Humans ; Therapeutic Equivalency
Czasopismo naukowe
Tytuł:
Mechanistic modeling of drug products applied to the skin: A workshop summary report.
Autorzy:
Tsakalozou E; Division of Quantitative Methods and Modeling, Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Alam K; Division of Quantitative Methods and Modeling, Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Ghosh P; Division of Therapeutic Performance I, Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Spires J; Simulations Plus, Inc., Lancaster, California, USA.
Polak S; Certara UK, Simcyp Division, Sheffield, UK.; Jagiellonian University Medical College, Krakow, Poland.
Fang L; Division of Quantitative Methods and Modeling, Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Sammeta S; Teva Pharmaceuticals, Salt Lake City, Utah, USA.
Zhao P; Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Arora S; Certara UK, Simcyp Division, Sheffield, UK.; Janssen Pharmaceutical, Companies of Johnson & Johnson, Beerse, Belgium.
Raney SG; Division of Therapeutic Performance I, Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 May; Vol. 12 (5), pp. 575-584. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji:
Journal Article; Review; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Drugs, Generic*
Research Report*
Humans ; Pharmaceutical Preparations ; Skin ; Therapeutic Equivalency
Czasopismo naukowe
Tytuł:
Dissolution profile evaluation of selected brands of amoxicillin-clavulanate potassium 625 mg tablets retailed in Hawassa town, Sidama Regional State, Ethiopia.
Autorzy:
Endashaw, Eyob (AUTHOR)
Tatiparthi, Ramanjireddy (AUTHOR)
Mohammed, Tesfaye (AUTHOR)
Teshome, Henok (AUTHOR)
Duguma, Markos (AUTHOR)
Tefera, Yesuneh (AUTHOR)
Pokaż więcej
Źródło:
AAPS Open. 4/1/2024, Vol. 10 Issue 1, p1-12. 12p.
Czasopismo naukowe
Tytuł:
Fast learning without synaptic plasticity in spiking neural networks.
Autorzy:
Subramoney A; Institute for Theoretical Computer Science, Graz University of Technology, Graz, Austria.; Department of Computer Science, Royal Holloway University of London, Egham, UK.
Bellec G; Institute for Theoretical Computer Science, Graz University of Technology, Graz, Austria.; Laboratory of Computational Neuroscience, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Scherr F; Institute for Theoretical Computer Science, Graz University of Technology, Graz, Austria.
Legenstein R; Institute for Theoretical Computer Science, Graz University of Technology, Graz, Austria.
Maass W; Institute for Theoretical Computer Science, Graz University of Technology, Graz, Austria. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 12; Vol. 14 (1), pp. 8557. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Learning*
Brain*
Neuronal Plasticity ; Drugs, Generic ; Neural Networks, Computer
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies